Malignant melanoma: interaction with coagulation and fibrinolysis pathways in situ

MZ Wojtukiewicz, LR Zacharski… - American journal of …, 1990 - academic.oup.com
MZ Wojtukiewicz, LR Zacharski, VA Memoli, W Kisiel, BJ Kudryk, SM Rousseau, DC Stump
American journal of clinical pathology, 1990academic.oup.com
Immunohistochemical techniques applied to fresh frozen sections of metastatic malignant
melanoma tissue revealed abundant fibrinogen (or fibrin I) in perivascular areas throughout
the tumor connective tissue stroma. Fibrin was readily detected in a focal distribution in the
connective tissue around nodules of viable tumor. Staining for D-dimer of cross-linked fibrin
(using an antibody that cross-reacted with fragment D of fibrinogen) coincided with staining
for fibrin. Diffuse staining of tumor cell bodies was observed for Factor X, and Factor XIII (“a” …
Abstract
Immunohistochemical techniques applied to fresh frozen sections of metastatic malignant melanoma tissue revealed abundant fibrinogen (or fibrin I) in perivascular areas throughout the tumor connective tissue stroma. Fibrin was readily detected in a focal distribution in the connective tissue around nodules of viable tumor. Staining for D-dimer of cross-linked fibrin (using an antibody that cross-reacted with fragment D of fibrinogen) coincided with staining for fibrin. Diffuse staining of tumor cell bodies was observed for Factor X, and Factor XIII (“a” subunit) was detected in scattered areas of connective tissue throughout the tumors. Factor VII was not detected, and only rare tumor cells stained for tissue factor. These results support the concept that a tumor cell-associated, thrombin-generating pathway exists in situ in malignant melanoma tissue that includes Factor X but neither tissue factor nor Factor VII. By contrast, tumor cell staining was observed rarely for urokinase and to a variable extent for tissue plasminogen activator.
Oxford University Press